PREVALENCE OF EXTRAINTESTINAL MANIFESTATIONS AMONG PATIENTS WITH ULCERATIVE COLITIS
Main Article Content
Keywords
Ulcerative colitis, Extraintestinal manifestations, predictors
Abstract
Objective: Prevalence of extraintestinal manifestations among patients with ulcerative colitis.
Methodology: We initiated a cross sectional study on 180 patients presenting with ulcerative colitis having age 18 to 65 years of either gender. Prevalence of EIMs and its predictors were assessed.
Results: The mean age was 40.77±14.20 years. Prevalence of EIMs was 84 (46.7%). Nineteen (22.6%) EIM patients had pancolitis, Thirty six (42.9%) had arthritis, and 23 (27.4%) had colectomy. Predictors such pancolitis, arthritis, and colectomy were connected to extraintestinal symptoms.
Conclusion: Prevalence of extraintestinal manifestations among patients with ulcerative colitis was 84 (46.7%)
References
2. Gros B, Kaplan GG. Ulcerative colitis in adults. JAMA. 2023;330(10):951-65.
3. Segal JP, LeBlanc JF, Hart AL. Ulcerative colitis: an update. Clin Med. 2021;21(2):135-42.
4. Hata K, Okada S, Shinagawa T, Toshiaki T, Kawai K, Nozawa H. Meta-analysis of the association of extraintestinal manifestations with the development of pouchitis in patients with ulcerative colitis. BJS Open. 2019;3(4):436-44.
5. Marotto D, Atzeni F, Ardizzone S, Monteleone G, Giorgi V, Sarzi-Puttini P. Extra-intestinal manifestations of inflammatory bowel diseases. Pharmacol Res. 2020;161:105206.
6. Guillo L, D’amico F, Serrero M, Angioi K, Loeuille D. Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials. United European Gastroenterol J. 2020;8(9):1013-30.
7. Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res. 2020;18(3):249-64.
8. Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease. Radiographics. 2017;37(4):1135-60.
9. Woźniak M, Kurnatowska I, Małecka-Panas E, Talar-Wojnarowska R. Leukocytapheresis in patients with inflammatory bowel diseases. Gastroenterology. 2021;16(2):99-105.
10. Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease–epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019;13(4):307-17.
11. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut. 1996;38(5):738.
12. Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10(10):585-95.
13. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease: a prospective study of 792 patients. J Clin Gastroenterol. 1996;23(1):29-34.
14. Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63–8.
15. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–9.
16. Peeters H, Vander Cruyssen B, Mielants H, de Vlam K, Vermeire S, Louis E, et al. Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol. 2008;23:132–7.
17. Leclerc-Jacob S, Lux G, Rat AC, Laurent V, Blum A, Chary-Valckenaere I, et al. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: A retrospective study performed on 186 patients. Aliment Pharmacol Ther. 2014;39:957–62.
18. Yamamoto-Furusho JK, Sánchez-Morales GE. Factors Associated with the Presence of Extraintestinal Manifestations in Patients with Ulcerative Colitis in a Latin American Country. Inflamm Intestin Dis. 2020;5(4):200-4.
19. Hernandez-Tejero M, Granja-Navacerrada A, Bernal-Checa P, Pique-Becerra R, Algaba-Garcia A, Guerra-Marina I, et al. Prevalence, risk factors and response to treatment of extraintestinal manifestations in patients with inflammatory bowel disease. Revista Espanola de Enfermadades Digestivas (REED). 2017;109(9):627-33.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Noman Khan
Senior Registrar, Department of Gastroenterology, Prime Teaching Hospital, Peshawar - Pakistan
Wajid Iqbal
Senior Registrar Department of Gastroenterology, Timergara Teaching Hospital, Dir Lower - Pakistan
Younas Ahmad
Assistant Professor, Department of Gastroenterology, Jinnah Medical College & Teaching Hospital, Peshawar - Pakistan
Shah Nawaz Khatti
Assistant Professor, General Surgery, Liaquat University of Medical and Health Sciences, Jamshoro - Pakistan
Asma Abdul Razzak
Assistant Professor Gastroenterology, Medicare Cardiac and General Hospital (Jinnah Medical Dental College), Karachi - Pakistan
Vineesha
Liaquat National Hospital and Medical College, Karachi - Pakistan